Literature DB >> 16672414

Sensitivity of the Multispot HIV-1/HIV-2 rapid test using samples from human immunodeficiency virus type 1-positive individuals with various levels of exposure to highly active antiretroviral therapy.

Robert J O'Connell1, Brian K Agan, Stephanie A Anderson, Jennifer A Malia, Nelson L Michael.   

Abstract

The Multispot HIV-1/HIV-2 rapid test detects human immunodeficiency virus type 1 (HIV-1) gp41 antibodies, which can wane over time in some HIV-1-infected populations, resulting in false-negative screening results. Multispot sensitivity was 100% using 248 sera from one such population, and it correctly identified serostatus in individuals who previously tested false negative with rapid testing.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16672414      PMCID： PMC1479184          DOI： 10.1128/JCM.44.5.1831-1833.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  8 in total

1.  HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression.

Authors:  C J Pitcher; C Quittner; D M Peterson; M Connors; R A Koup; V C Maino; L J Picker
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

2.  Evaluation of three rapid tests for detection of antibodies to HIV-1 non-B subtypes.

Authors:  Africa Holguín
Journal:  J Virol Methods       Date:  2004-01       Impact factor: 2.014

3.  Pilot study of expedited HIV-1 testing of women in labor at an inner-city hospital in New York City.

Authors:  M P Webber; P Demas; E Enriquez; R Shanker; W Oleszko; S T Beatrice; E E Schoenbaum
Journal:  Am J Perinatol       Date:  2001       Impact factor: 1.862

4.  ImmunoConcentration--a new format for solid-phase immunoassays.

Authors:  G E Valkirs; R Barton
Journal:  Clin Chem       Date:  1985-09       Impact factor: 8.327

5.  Selective increases in HIV-specific neutralizing antibody and partial reconstitution of cellular immune responses during prolonged, successful drug therapy of HIV infection.

Authors:  J H Kim; J R Mascola; S Ratto-Kim; T C VanCott; L Loomis-Price; J H Cox; N L Michael; L Jagodzinski; C Hawkes; D Mayers; B L Gilliam; D C Birx; M L Robb
Journal:  AIDS Res Hum Retroviruses       Date:  2001-07-20       Impact factor: 2.205

6.  Diagnosis of human immunodeficiency virus type 1 infection with different subtypes using rapid tests.

Authors:  S Phillips; T C Granade; C P Pau; D Candal; D J Hu; B S Parekh
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

7.  Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapy.

Authors:  Robert J O'Connell; Teresa M Merritt; Jennifer A Malia; Thomas C VanCott; Matthew J Dolan; Hassan Zahwa; William P Bradley; Bernard M Branson; Nelson L Michael; Caroline C De Witt
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

8.  HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy.

Authors:  L Morris; J M Binley; B A Clas; S Bonhoeffer; T P Astill; R Kost; A Hurley; Y Cao; M Markowitz; D D Ho; J P Moore
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307
  8 in total
  5 in total

1.  What's the Point? How Point-of-Care STI Tests Can Impact Infected Patients.

Authors:  Jill Huppert; Elizabeth Hesse; Charlotte A Gaydos
Journal:  Point Care       Date:  2010-03-01

2.  Understanding low sensitivity of community-based HIV rapid testing: experiences from the HPTN 071 (PopART) trial in Zambia and South Africa.

Authors:  Peter Bock; Comfort Phiri; Estelle Piwowar-Manning; Barry Kosloff; Nomtha Mandla; Alicia Young; Anelet James; Ab Schaap; Michelle Scheepers; Deborah Donnell; Sam Griffith; Wafaa El-Sadr; Kwame Shanaube; Nulda Beyers; Richard Hayes; Sarah Fidler; Helen Ayles
Journal:  J Int AIDS Soc       Date:  2017-08-29       Impact factor: 5.396

3.  HIV-1/2 differentiation in a South African public laboratory.

Authors:  Rendani T Mafuyeka; Lynne M Webber; Piet Becker; Simnikiwe H Mayaphi
Journal:  South Afr J HIV Med       Date:  2021-03-12       Impact factor: 2.744

4.  Influence of Combination Antiretroviral Therapy on HIV-1 Serological Responses and Their Implications: A Systematic Review and Meta-Analysis.

Authors:  Yuanhao Liang; Hongqing Lin; Emmanuel Enoch Dzakah; Shixing Tang
Journal:  Front Immunol       Date:  2022-03-30       Impact factor: 7.561

5.  Does antiretroviral therapy use affect the accuracy of HIV rapid diagnostic assays? Experience from a demographic health and surveillance site in rural South Africa.

Authors:  Mark J Siedner; Kathy Baisley; Olivier Koole; Innocentia Mpofana; Gregory Ording-Jespersen; Philippa Matthews; Kobus Herbst; Theresa Smit; Deenan Pillay
Journal:  Diagn Microbiol Infect Dis       Date:  2020-03-02       Impact factor: 2.803
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.